Belvedere Trading’s NanoViricides NNVC Stock Holding History

Belvedere Trading’s Portfolio NNVC Stock Details NNVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-28	Closed	–	–	563
2021 Q3	$0	Buy	+28	New	+$117	﹤0.01%	550

Other funds holding NNVC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

CLOS

Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $9.25B AUM 27.04% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

Belvedere Trading's NNVC Position: Q4 2021 in Review

Belvedere Trading sold out of NanoViricides (NNVC) in Q4 2021, closing a stake of 28 shares.

Belvedere Trading first reported a position in NNVC in Q3 2021 and held it in 1 quarter. The position peaked at $0 in Q3 2021. 29 funds tracked by Wall St. Rank hold NNVC as of Q4 2021.

Belvedere Trading reported no remaining NanoViricides position as of Q4 2021 after selling out during the quarter.
Belvedere Trading sold 28 NanoViricides shares in Q4 2021.
Belvedere Trading first reported a position in NanoViricides in Q3 2021 and held it in 1 quarter.
Belvedere Trading's NanoViricides position peaked at $0 in Q3 2021.
29 funds tracked by Wall St. Rank held NanoViricides as of Q4 2021.

Based on Belvedere Trading's 13F filing for Q4 2021, filed 25 Jan 2022.